Tyrell J. Rivers, Ph.D., Dr. Rivers has been Vice President, Corporate Ventures at AstraZeneca since 2014. From 2009 to 2014, Dr. Rivers was at MedImmune Ventures specializing in biotechnology investing. Dr. Rivers also serves as a member of the board of directors of ADC Therapeutics SA, Cerapedics, Inc., and Quell Therapeutics, Ltd. Dr. Rivers holds a B.S. in chemical engineering from the Massachusetts Institute of Technology, a Ph.D. in chemical engineering from the University of Texas at Austin and an M.B.A. from New York University Stern School of Business.